| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023910261 |
| P356 | DOI | 10.1038/MODPATHOL.2012.60 |
| P932 | PMC publication ID | 3410251 |
| P698 | PubMed publication ID | 22481283 |
| P5875 | ResearchGate publication ID | 223987389 |
| P50 | author | Sarah J Storr | Q40004090 |
| Steve Chan | Q43285180 | ||
| Stewart Martin | Q50482075 | ||
| Ian Ellis | Q55300055 | ||
| P2093 | author name string | Lei Zhang | |
| Ahmad Al-Attar | |||
| Mohamed Shehata | |||
| Caroline M Woolston | |||
| P2860 | cites work | Free radicals and antioxidants in normal physiological functions and human disease | Q21710698 |
| Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer | Q22000765 | ||
| The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. | Q24535620 | ||
| VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression | Q28181623 | ||
| Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function | Q28506375 | ||
| Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer | Q33645338 | ||
| Persistent oxidative stress in cancer | Q34315954 | ||
| Reactive oxygen species in oncogenic transformation | Q35594351 | ||
| Redox-sensitive signaling factors as a novel molecular targets for cancer therapy | Q36288505 | ||
| Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status | Q36467856 | ||
| Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients | Q36613823 | ||
| Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer | Q36695226 | ||
| Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure | Q36994850 | ||
| VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway | Q38503203 | ||
| Redox protein expression predicts radiotherapeutic response in early-stage invasive breast cancer patients. | Q39785464 | ||
| Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells | Q40373992 | ||
| Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications | Q40607183 | ||
| Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. | Q40630820 | ||
| Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. | Q40717111 | ||
| Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. | Q42814050 | ||
| Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy | Q43139246 | ||
| Prognostic significance of glutathione S-transferase-pi in invasive breast cancer | Q44478923 | ||
| REporting recommendations for tumor MARKer prognostic studies (REMARK). | Q46099462 | ||
| Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria | Q47378801 | ||
| Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy. | Q53311016 | ||
| Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas. | Q54042038 | ||
| Expression of p53 and glutathione S-transferase-pi relates to clinical drug resistance in non-small cell lung cancer. | Q54071252 | ||
| Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue | Q64445223 | ||
| A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer | Q70524874 | ||
| 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage | Q74462142 | ||
| Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy | Q74611825 | ||
| Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancer | Q77554294 | ||
| Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review) | Q77678739 | ||
| P433 | issue | 8 | |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 1106-1116 | |
| P577 | publication date | 2012-04-06 | |
| P1433 | published in | Modern Pathology | Q15724578 |
| P1476 | title | The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer | |
| P478 | volume | 25 |
| Q38209675 | A paradoxical chemoresistance and tumor suppressive role of antioxidant in solid cancer cells: a strange case of Dr. Jekyll and Mr. Hyde |
| Q55021652 | Anticancer Properties of Fenofibrate: A Repurposing Use. |
| Q39024621 | Mechanisms underlying the biological changes induced by isocitrate dehydrogenase-1 mutation in glioma cells |
| Q38805972 | Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na(+)/K(+)-ATPase and cell survival |
| Q35550156 | TXNIP interaction with the Her-1/2 pathway contributes to overall survival in breast cancer |
| Q48214395 | The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy. |
| Q37715775 | Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer |
| Q37133536 | Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma |
| Q95724864 | Thioredoxin-Interact ing-Pro t e in [TXNIP] and Transglutaminase 2 [TGM2] Expression in Meningiomas of Different Grades and the Role of Their Expression in Meningioma Recurrence and Prognosis |
| Q59573851 | Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ |
Search more.